The trial will test several treatment approaches in the maintenance setting for extensive stage small cell lung cancer.

Delhi has long stood as a beacon of modern healthcare. The national capital is home to gleaming hospitals, internationally trained specialists and cutting-edge treatments. Its medical tourism industry ...

Exelixis EXEL has put up a stellar performance so far this year. Shares of the biotech company have rallied 35.2% in the past three months compared with the industry’s growth of 11.8%. The stock has ...

Late-stage trials showed that Tecentriq combined with lurbinectedin led to a 46% reduction in the risk of the disease progressing or death, the company said.

Tecentriq may be used with the chemotherapy medicines carboplatin and etoposide as your first treatment when your lung cancer: is a type called “extensive-stage small cell lung cancer,” which ...

Tecentriq and chemotherapy combination reduces the risk of death versus chemotherapy alone in deficient mismatch repair, stage 3 colorectal cancer.

Among patients with ES-SCLC, first-line maintenance therapy with Zepzelca plus Tecentriq led to improvements in PFS and OS versus Tecentriq alone.

The US Food and Drug Administration (FDA) has approved Roche's Tecentriq Hybreza, a subcutaneous anti-PD-(L)1 cancer immunotherapy. The treatment offers a quicker and more comfortable ...

Basel, 13 September 2024- Roche announced today that the U.S. Food and Drug Administration has approved Tecentriq Hybreza TM, the first and only PD- 1 inhibitor for subcutaneous, under the skin ...

With Tecentriq Hybreza and Roche/Genentech’s 13 other subcutaneous therapies – available across various diseases – we offer additional administration options to meet the diverse preferences ...

Tecentriq is a prescription drug used to treat certain forms of cancer. Learn about the drug’s dosages, form, strength, and more.